Harshal J Profile

Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User – Global Forecast to 2030

The Single-use Bioreactors Market is projected to reach $10.3 billion by 2030, at a CAGR of 15.8% from 2023 to 2030. Single-use bioreactors, also called disposable bioreactors, are made of disposable bags instead of a culture vessel. These bioreactors eliminate the need for expensive and bulky clean-in-place (CIP) or steam-in-place (SIP) systems and offer flexibility and a low risk of contamination, contributing to their adoption by pharma & biotech companies. These companies are focusing on organic & inorganic strategies like expanding manufacturing capacity or acquisitions to increase their bioproduction, increasing the adoption of biopharma equipment, including bioreactors.

For instance, in December 2022, Thermo Fisher Scientific Inc. (U.S.) expanded its presence in Hangzhou, China, to support customers' manufacturing needs, enabling them to serve more patients worldwide. This site offers integrated clinical and commercial drug substance and drug product capabilities, including process development, cell line development, biologics drug substance manufacturing and sterile fill-finish. This includes the use of packaging and labeling capabilities. Advanced technologies in the facility include Thermo Fisher 2,000-liter HyPerforma Single-Use Bioreactors and associated Single-Use equipment and, in the future, bioreactor capacity up to 5,000 liters through Thermo Scientific DynaDrive technology.

In March 2021, Pall Corporation (U.S.), a subsidiary of Danaher Corporation (U.S.), acquired Pall-Austar Lifesciences Limited (Hong Kong) (a joint Venture between Pall and Austar Group). This acquisition is intended to expand the single-use technology manufacturing capabilities of the company in China for products supporting the scale-up of COVID-19 vaccines.

The rapid adoption of disposable technology in the pharmaceutical and biotechnology industry, growing demand for biopharmaceuticals, and capacity expansion of biopharmaceutical plants are some of the major factors driving the growth of the single-use bioreactors market.

Network Security Firewall Market by Component (Solutions, Services), Type (Unified Threat Management, Next-generation Firewall), Deployment Mode, Organization Size, and Sector (BFSI, Retail, and Other Sectors) and Geography – Global Forecast to 2030

The Network Security Firewall Market to reach $16.2 billion by 2030 at a CAGR of 19.7% during 2023–2030. The growth of the network security firewall market is driven by the rising government regulations encouraging the demand for network security firewalls, the growing significance of network security firewall solutions in the BFSI sector, the increasing demand for network security and privacy, and the advancement of digital transformation in the telecommunication industry. However, the lack of preventive firewall maintenance restrains the growth of the network security firewall market.

Further, the growing need for network security firewall solutions among SMEs and increasing adoption of network function virtualization is expected to create market growth opportunities. Also, misconceptions & lack of knowledge regarding network security firewall solutions are challenging for the players operating in this market.

Antiviral & Antimicrobial Coatings Market by Type (Antimicrobial, Antiviral), Material (Copper, Silver, Aluminum), Form (Powder, Aerosol), Application (Healthcare, Building & Construction, Automotive, Packaging), and Geography – Forecast to 2028

The Antiviral & Antimicrobial Coatings Market is expected to grow at a CAGR of 11.7% from 2021 to 2028 to reach $8.53 billion by 2028. Antiviral & antimicrobial coatings are used to restrict the growth of viruses and other microorganisms. These coatings provide long-lasting protection against microorganisms and help maintain permanent hygiene. They have wide applications in healthcare, building & construction, food & beverage, packaging, air & water treatment, automotive, protective clothing, and other industries like oil & gas, electronics, and aeronautics & defense.

The growth of this market is mainly attributed to the increasing incidence of healthcare-associated infections, the rising number of food product recalls due to microbial contamination, and government initiatives & funding for the development of antimicrobial coatings. Favorable development in the emerging economies is expected to offer significant growth opportunities for players in this market. However, stringent government regulation on the emission of volatile organic compounds (VOCs) is expected to restrain the growth of this market to a certain extent. Additionally, the growing antimicrobial resistance among micro-organisms is expected to pose challenges to market growth.

U.S. Water and Wastewater Treatment Technologies Market by Treatment Technologies Type (Membrane Separation & Filtration, Sludge Management Technology, Activated Sludge, Clarification) and Application – Forecasts to 2029

The U.S. Water and Wastewater Treatment Technologies Market is expected to reach a value of $24.63 billion by 2029, at a CAGR of 5% during the forecast period 2022–2029. The growth of the U.S. water and wastewater treatment technologies market is attributed to stringent regulations on the safe and appropriate use of onsite wastewater treatment systems (OWTS), improvements in wastewater treatment technology, and the increasing prevalence of waterborne diseases.

Furthermore, the growing demand for energy-efficient and advanced water treatment technologies is expected to provide significant growth opportunities for the vendors operating in the U.S. water and wastewater treatment technologies market. However, the high installation, maintenance, and operational costs are expected to hinder the growth of this market to a notable extent. In addition, the aging and deterioration of existing water infrastructure are the challenges for the growth of the U.S. water and wastewater treatment technologies market.

Snacks Processing Equipment Market by Type (Conveyers, Sorting, Dryers, Mixing, Cutting, Coating, Packaging, Mode of Operation (Semi/Manual, Automatic), Snack Type (Chips, Extruded Snacks, Bakery & Confectionery), and Geography – Global Forecast to 2030

The Snacks Processing Equipment Market is projected to reach $1.7 billion by 2030, at a CAGR of 6% during the forecast period 2023–2030. The growth of the snacks processing equipment market is driven by the growing consumption of healthy snacks, the rising demand for processed/convenience foods, and consumers’ increased focus on food hygiene since the COVID-19 pandemic. However, the high cost of snack processing equipment restrains the growth of this market. Furthermore, increasing government support for the food processing industry is expected to generate growth opportunities for the players operating in this market. However, the shortage of trained labor and consumers’ increasing inclination toward minimally processed food products are major challenges impacting the market’s growth.

Additionally, the integration of automation and smart technologies into snack processing equipment is a key trend in the global snacks processing equipment market.

Veterinary Molecular Diagnostics Market by Product (Kits & Reagents, System & Software), Technology (PCR, Microarray, DNA Seq), Animal Type (Companion, Livestock), Application (Infectious Disease, Genetics), End User (Hospital, Clinical Lab) – Forecast to 2029

The Veterinary Molecular Diagnostics Market is expected to grow at a CAGR of 9.2% from 2022 to 2029 to reach $1.13 billion by 2029. Factors such as the growing pet animal population, high animal healthcare expenditure, ongoing advancements in veterinary molecular diagnostics, and the high sensitivity and specificity of MDx tests are supporting the market growth. Moreover, emerging markets, advancements in veterinary diagnostics technologies, and increasing efforts by organizations to promote animal welfare are expected to offer opportunities for the global veterinary molecular diagnostics market.

Veterinary Rapid Diagnostic Tests Market by Product (Kits, Readers), Condition (Viral, Parasitic, Bacterial Infections), Animal (Companion [Dogs, Cats], Livestock), and End User (Clinics & Hospitals, Reference Labs, Home Testing) – Global Forecast to 2030

The Veterinary Rapid Diagnostic Tests Market is expected to record a CAGR of 8.1% from 2023 to 2030, reaching $1.1 billion by 2030. The growth of this market is driven by the increasing prevalence of zoonotic diseases, the advantages of rapid tests over other testing methods, the growing preference for at-home and farm testing, rising awareness regarding veterinary health, increasing global animal health expenditure, and the increasing demand for animal-derived food products.

However, the lack of reimbursements and the preference for certain traditional diagnostic methods restrain the growth of this market. Additionally, emerging markets and increasing pet ownership are expected to create growth opportunities for the stakeholders in this market. However, the inadequate diagnostic infrastructure in developing countries and farmers’ lack of awareness regarding animal health are major challenges to market growth.

Fungal Protein Market By Type (Fusarium Venenatum Extract, Mushrooms, Yeast Extract), Application (Food & Beverage {Beverages, Bakery}, Animal Nutrition {Poultry Feed, Aquafeed}, Pharmaceuticals, and Other Applications), and Geography – Global Forecast to 2029

In terms of value, the global fungal protein market is projected to reach $397.5 million by 2029, at a CAGR of 7.6% from 2023 to 2029. Moreover, this market is projected to reach 23,185 tons by 2029, at a CAGR of 6.2% during the forecast period 2023–2029.The popularity of fungal protein is on the rise as it is rich in proteins, vitamins, folic acid, and minerals, making it an ideal choice for use in both human food & beverages, animal feed, and pharmaceutical applications.

The growth of the fungal protein market is primarily driven by the growing demand for allergen-free foods, the rising consumption of processed foods, and the increasing demand for meat substitutes. Additionally, the rising adoption of yeast extract in the processed foods industry and emerging economies in Asia-Pacific and the Middle East are expected to provide significant market growth opportunities. However, undefined regulatory guidelines are expected to restrain the growth of this market.

Robotic Welding Market by Component (Robots, End of Arm Tooling, Controllers), Welding Process, Payload (Less than 25 kg Payload, 25 kg to 100 kg Payload, More than 100 kg Payload), End-use Industry, and Geography – Global Forecast to 2029

The Robotic Welding Market is expected to reach $6.77 billion by 2029, at a CAGR of 6.2% during the forecast period of 2022–2029. By volume, this market is expected to reach 163.3 thousand units by 2029, at a CAGR of 11.2% from 2022 to 2029. The growth of this market is driven by the increasing adoption of industry 4.0 principles and the rising adoption of welding robots in the automotive industry. However, the high initial cost of installing welding robots is expected to restrain the growth of this market.

Government initiatives to support digital transformation in Asia-Pacific and the emergence of laser & plasma welding technologies are expected to provide significant growth opportunities for stakeholders in this market. However, the lack of skilled workers for operating welding robots is expected to pose a major challenge to the growth of this market.

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User (Hospital, Diagnostic Center) – Global Forecast to 2029

The Artificial Intelligence in Medical Diagnostics Market is expected to reach $9.38 billion by 2029, at a CAGR of 36.2% from 2022 to 2029. Artificial intelligence (AI) in medical diagnostics is a powerful tool that has the potential to make healthcare more accessible and affordable by assisting healthcare providers in making accurate and quick treatment decisions for their patients. The accurate diagnosis of a disease takes years of medical training and is a time-consuming process. The use of AI in medical diagnosis has proven to give accurate diagnoses, aid in clinical decisions, and enhance physicians' judgment.

AI in medical diagnostics includes AI solutions that aid physicians with medical decision-making. AI-based solutions can be used to diagnose cancer, triage critical findings in medical imaging, flag acute abnormalities, help radiologists prioritize life-threatening cases, diagnose cardiac arrhythmias, predict stroke outcomes, and help with the management of chronic diseases.

The growth of this market is driven by the growing need for the adoption of AI in medical diagnosis to reduce errors, the shortage of healthcare professionals, and the rising incidence rate of chronic diseases. In addition, the growth potential in emerging economies and the growing number of cross-industry partnerships & collaborations are expected to provide significant growth opportunities for this market.

However, the reluctance to adopt AI technologies due to a lack of trust is expected to restrain the growth of this market. In addition, factors such as regulatory barriers and privacy & security concerns are the major challenges to the growth of this market